Research ArticleArticle
Open Access
Results From the 2020 Canadian Rheumatology Association's Workforce and Wellness Survey
Stephanie C. Kulhawy-Wibe, Jessica Widdifield, Jennifer J.Y. Lee, J. Carter Thorne, Elaine A. Yacyshyn, Michelle Batthish, Dana Jerome, Rachel Shupak, Konstantin Jilkine, Jane Purvis, Justin Shamis, Janet Roberts, Jason Kur, Jennifer E. Burt, Nicole A. Johnson, Cheryl Barnabe, Nicole M.S. Hartfeld, Mark Harrison, Janet Pope and Claire E.H. Barber
The Journal of Rheumatology February 2022, jrheum.210990; DOI: https://doi.org/10.3899/jrheum.210990
Stephanie C. Kulhawy-Wibe
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Jessica Widdifield
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Jennifer J.Y. Lee
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
J. Carter Thorne
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Elaine A. Yacyshyn
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Michelle Batthish
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Dana Jerome
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Rachel Shupak
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Konstantin Jilkine
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Jane Purvis
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Justin Shamis
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Janet Roberts
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Jason Kur
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Jennifer E. Burt
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Nicole A. Johnson
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Cheryl Barnabe
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Nicole M.S. Hartfeld
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Mark Harrison
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Janet Pope
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Claire E.H. Barber
CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.
Abstract
Objective The Canadian Rheumatology Association (CRA) launched the Workforce and Wellness Survey to update the Canadian rheumatology workforce characteristics.
Methods The survey included demographic and practice information, pandemic effects, and the Mini Z survey to assess burnout. French and English survey versions were distributed to CRA members electronically between October 14, 2020, and March 5, 2021. The number of full-time equivalent (FTE) rheumatologists per 75,000 population was estimated from the median proportion of time in clinical practice multiplied by provincial rheumatologist numbers from the Canadian Medical Association.
Results Forty-four percent (183/417) of the estimated practicing rheumatologists (149 adult; 34 pediatric) completed the survey. The median age was 47 years, 62% were female, and 28% planned to retire within the next 5–10 years. Respondents spent a median of 65% of their time in clinical practice. FTE rheumatologists per 75,000 population were 0.62 nationally and ranged between 0.00 and 0.70 in each province/territory. This represents a deficit of 1–78 FTE rheumatologists per province/territory and 194 FTE rheumatologists nationally to meet the CRA's workforce benchmark. Approximately half of survey respondents reported burnout (51%). Women were more likely to report burnout (OR 2.86, 95% CI 1.42–5.93). Older age was protective against burnout (OR 0.95, 95% CI 0.92–0.99). As a result of the pandemic, 97% of rheumatologists reported spending more time engaged in virtual care.
Conclusion There is a shortage of rheumatologists in Canada. This shortage may be compounded by the threat of burnout to workforce retention and productivity. Strategies to address these workforce issues are needed urgently.
In this issue
The Journal of Rheumatology
Vol. 50, Issue 3
1 Mar 2023
Results From the 2020 Canadian Rheumatology Association's Workforce and Wellness Survey
Stephanie C. Kulhawy-Wibe, Jessica Widdifield, Jennifer J.Y. Lee, J. Carter Thorne, Elaine A. Yacyshyn, Michelle Batthish, Dana Jerome, Rachel Shupak, Konstantin Jilkine, Jane Purvis, Justin Shamis, Janet Roberts, Jason Kur, Jennifer E. Burt, Nicole A. Johnson, Cheryl Barnabe, Nicole M.S. Hartfeld, Mark Harrison, Janet Pope, Claire E.H. Barber
The Journal of Rheumatology Feb 2022, jrheum.210990; DOI: 10.3899/jrheum.210990
Results From the 2020 Canadian Rheumatology Association's Workforce and Wellness Survey
Stephanie C. Kulhawy-Wibe, Jessica Widdifield, Jennifer J.Y. Lee, J. Carter Thorne, Elaine A. Yacyshyn, Michelle Batthish, Dana Jerome, Rachel Shupak, Konstantin Jilkine, Jane Purvis, Justin Shamis, Janet Roberts, Jason Kur, Jennifer E. Burt, Nicole A. Johnson, Cheryl Barnabe, Nicole M.S. Hartfeld, Mark Harrison, Janet Pope, Claire E.H. Barber
The Journal of Rheumatology Feb 2022, jrheum.210990; DOI: 10.3899/jrheum.210990
